Open AccessComparison of Outcomes Post Autologous Stem Cell Transplant (ASCT) in Patients with Multiple Myeloma (MM) Based on Dosage of Melphalan (mel) As Part of Conditioning Therapy: Single Institutional Experience of a Large Study Group
Author(s) -
Nidhi Sharma,
Qiuhong Zhao,
Abdullah Khan,
Naresh Bumma,
Maria Chaudhry,
Ashley Rosko,
Don M. Benson,
Yvonne A. Efebera,
Srinivas Devarakonda
Publication year - 2020
Publication title -
biology of blood and marrow transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.301
H-Index - 120
eISSN - 1523-6536
pISSN - 1083-8791
DOI - 10.1016/j.bbmt.2019.12.475
Subject(s) - medicine , melphalan , multiple myeloma , hazard ratio , proportional hazards model , retrospective cohort study , oncology , surgery , progression free survival , transplantation , autologous stem cell transplantation , chemotherapy , confidence interval
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom